Is There An Opportunity With ST Pharm Co.,Ltd.'s (KOSDAQ:237690) 22% Undervaluation?
Dec 30
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedDec 30, 2025
DataAggregated Company Financials
Companies371
- 7D0.8%
- 3M12.9%
- 1Y27.3%
- YTD31.3%
The Healthcare is pretty flat in the last 7 days, but Samsung Epis Holdings has stood out, gaining 14%. As for the the longer term, the industry is up 27% over the past 12 months. Earnings are forecast to grow by 35% annually.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 31 Dec 2025 | ₩367.0t | ₩61.9t | ₩2.7t | 18.9x | 135.7x | 5.9x |
| Fri, 28 Nov 2025 | ₩348.2t | ₩61.8t | ₩2.8t | 18.9x | 124.3x | 5.6x |
| Sun, 26 Oct 2025 | ₩311.3t | ₩60.3t | ₩2.1t | 19.9x | 150.5x | 5.2x |
| Tue, 23 Sep 2025 | ₩312.3t | ₩60.1t | ₩1.9t | 21.6x | 161.3x | 5.2x |
| Thu, 21 Aug 2025 | ₩285.3t | ₩59.3t | ₩2.0t | 21.3x | 141.8x | 4.8x |
| Sat, 19 Jul 2025 | ₩303.6t | ₩58.2t | ₩1.5t | 22.7x | 207x | 5.2x |
| Mon, 16 Jun 2025 | ₩275.1t | ₩57.8t | ₩1.6t | 21.5x | 177.1x | 4.8x |
| Wed, 14 May 2025 | ₩261.9t | ₩56.2t | ₩1.4t | 19.2x | 193.7x | 4.7x |
| Fri, 11 Apr 2025 | ₩258.1t | ₩56.1t | ₩1.3t | 18x | 196x | 4.6x |
| Sun, 09 Mar 2025 | ₩276.3t | ₩54.9t | ₩867.4b | 14.6x | 318.5x | 5x |
| Tue, 04 Feb 2025 | ₩267.3t | ₩54.6t | ₩831.2b | 14.3x | 321.6x | 4.9x |
| Thu, 02 Jan 2025 | ₩257.7t | ₩54.6t | ₩808.0b | 14.2x | 318.9x | 4.7x |
| Sat, 30 Nov 2024 | ₩250.4t | ₩54.3t | ₩908.5b | 13.3x | 275.6x | 4.6x |
| Mon, 28 Oct 2024 | ₩274.7t | ₩53.3t | ₩854.8b | 16.5x | 321.3x | 5.2x |
| Wed, 25 Sep 2024 | ₩282.4t | ₩53.4t | ₩856.0b | 17.3x | 330x | 5.3x |
| Fri, 23 Aug 2024 | ₩261.9t | ₩53.0t | ₩946.0b | 15.6x | 276.9x | 4.9x |
| Sun, 21 Jul 2024 | ₩247.3t | ₩52.3t | ₩750.8b | 16.9x | 329.4x | 4.7x |
| Tue, 18 Jun 2024 | ₩226.7t | ₩53.0t | ₩740.6b | 16.2x | 306.2x | 4.3x |
| Thu, 16 May 2024 | ₩234.1t | ₩52.3t | ₩543.3b | 18.8x | 430.9x | 4.5x |
| Sat, 13 Apr 2024 | ₩231.4t | ₩52.3t | ₩524.4b | 17.8x | 441.3x | 4.4x |
| Mon, 11 Mar 2024 | ₩237.9t | ₩52.1t | -₩125,423,066,956.00 | 21.3x | -1896.6x | 4.6x |
| Wed, 07 Feb 2024 | ₩223.3t | ₩52.0t | -₩55,498,881,746.00 | 21.3x | -4023.6x | 4.3x |
| Fri, 05 Jan 2024 | ₩233.2t | ₩56.1t | ₩268.1b | 23.6x | 869.8x | 4.2x |
| Sun, 03 Dec 2023 | ₩209.2t | ₩56.1t | ₩274.9b | 21.2x | 761.1x | 3.7x |
| Tue, 31 Oct 2023 | ₩196.2t | ₩56.0t | ₩1.0t | 18.2x | 191.8x | 3.5x |
| Thu, 28 Sep 2023 | ₩205.1t | ₩56.0t | ₩1.0t | 18.7x | 200.3x | 3.7x |
| Sat, 26 Aug 2023 | ₩212.0t | ₩55.6t | ₩1.0t | 22.2x | 205.4x | 3.8x |
| Mon, 24 Jul 2023 | ₩210.7t | ₩56.1t | ₩2.1t | 21.2x | 100.1x | 3.8x |
| Wed, 21 Jun 2023 | ₩212.5t | ₩56.3t | ₩2.1t | 21.2x | 100.7x | 3.8x |
| Fri, 19 May 2023 | ₩213.6t | ₩58.6t | ₩3.4t | 21.3x | 63.1x | 3.6x |
| Sun, 16 Apr 2023 | ₩226.1t | ₩58.4t | ₩3.2t | 20.7x | 69.6x | 3.9x |
| Tue, 14 Mar 2023 | ₩201.4t | ₩57.9t | ₩4.4t | 17.8x | 46.3x | 3.5x |
| Thu, 09 Feb 2023 | ₩210.1t | ₩57.8t | ₩4.6t | 19.6x | 45.6x | 3.6x |
| Sat, 07 Jan 2023 | ₩203.3t | ₩58.0t | ₩4.4t | 15.8x | 46.5x | 3.5x |
Price to Earnings Ratio
46.5x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 136x which is lower than its 3-year average PE of 275x.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 5.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 15% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | 2.59% | |
| Healthcare | 0.79% | |
| Biotech | 2.48% | |
| Medical Equipment | 0.24% | |
| Healthcare Services | 0.19% | |
| Life Sciences | -0.24% | |
| Pharma | -1.13% | |
| Healthtech | -5.41% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
- Analysts expect its future annual earnings growth (45.9%) to be largely in line with prior year's earnings growth.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 46% over the next 5 years.
- This is roughly in line with its past earnings growth rate.
- In contrast, the Healthtech industry is expected to see its earnings decline by 31% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A0126Z0 Samsung Epis Holdings | ₩743.00k | 14.0% +₩2.3t | n/a | n/a | |
| A298380 ABL Bio | ₩200.00k | 7.0% +₩716.6b | 568.9% | PS124.7x | |
| A028300 HLB | ₩50.80k | 9.0% +₩552.7b | -30.5% | PS82.8x | |
| A196170 ALTEOGEN | ₩449.50k | 2.3% +₩534.8b | 45.2% | PE190.9x | |
| A475830 Orum Therapeutics | ₩120.00k | 26.1% +₩524.7b | n/a | PS99640.3x |
